|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Weigelt B, Peterse JL and van't Veer LJ:
Breast cancer metastasis: Markers and models. Nat Rev Cancer.
5:591–602. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Danen EH: Integrins: regulators of tissue
function and cancer progression. Curr Pharm Des. 11:881–891. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eliceiri BP and Cheresh DA: Adhesion
events in angiogenesis. Curr Opin Cell Biol. 13:563–568. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ruoslahti E: Specialization of tumour
vasculature. Nat Rev Cancer. 2:83–90. 2002. View Article : Google Scholar
|
|
6
|
Temming K, Schiffelers RM, Molema G and
Kok RJ: RGD-based strategies for selective delivery of therapeutics
and imaging agents to the tumour vasculature. Drug Resist Updat.
8:381–402. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Galvez AF and de Lumen BO: A soybean cDNA
encoding a chromatin-binding peptide inhibits mitosis of mammalian
cells. Nat Biotechnol. 17:495–500. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jeong HJ, Lam Y and de Lumen BO: Barley
lunasin suppresses ras-induced colony formation and inhibits core
histone acetylation in mammalian cells. J Agric Food Chem.
50:5903–5908. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeong HJ, Jeong JB, Kim DS, Park JH, Lee
JB, Kweon DH, Chung GY, Seo EW and de Lumen BO: The cancer
preventive peptide lunasin from wheat inhibits core histone
acetylation. Cancer Lett. 255:42–48. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Silva-Sánchez C, de la Rosa AP,
León-Galván MF, de Lumen BO, de León-Rodríguez A and de Mejía EG:
Bioactive peptides in amaranth (Amaranthus hypochondriacus) seed. J
Agric Food Chem. 56:1233–1240. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jeong JB, Jeong HJ, Park JH, Lee SH, Lee
JR, Lee HK, Chung GY, Choi JD and de Lumen BO: Cancer-preventive
peptide lunasin from Solanum nigrum L. inhibits acetylation of core
histones H3 and H4 and phosphorylation of retinoblastoma protein
(Rb). J Agric Food Chem. 55:10707–10713. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hernández-Ledesma B, Hsieh CC and de Lumen
BO: Relationship between lunasin's sequence and its inhibitory
activity of histones H3 and H4 acetylation. Mol Nutr Food Res.
55:989–998. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
de Lumen BO: Lunasin: a cancer-preventive
soy peptide. Nutr Rev. 63:16–21. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dia VP and Gonzalez de Mejia E: Lunasin
potentiates the effect of oxaliplatin preventing outgrowth of colon
cancer metastasis, binds to α5β1 integrin and
suppresses FAK/ERK/NF-κB signaling. Cancer Lett. 313:167–180. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cam A and de Mejia EG: RGD-peptide lunasin
inhibits Akt-mediated NF-κB activation in human macrophages through
interaction with the αVβ3 integrin. Mol Nutr
Food Res. 56:1569–1581. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hsieh CC, Hernandez-Ledesma B and de Lumen
B: Cell proliferation inhibitory and apoptosis-inducing properties
of anacardic acid and lunasin in human breast cancer MDA-MB-231
cells. Food Chem. 125:630–636. 2011. View Article : Google Scholar
|
|
17
|
Liang CC, Park AY and Guan JL: In vitro
scratch assay: a convenient and inexpensive method for analysis of
cell migration in vitro. Nat Protoc. 2:329–333. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xu L and Deng X: Protein kinase Ciota
promotes nicotine-induced migration and invasion of cancer cells
via phosphorylation of micro- and m-calpains. J Biol Chem.
281:4457–4466. 2006. View Article : Google Scholar
|
|
19
|
Li C, Zhao Y, Yang D, Yu Y, Guo H, Zhao Z,
Zhang B and Yin X: Inhibitory effects of kaempferol on the invasion
of human breast carcinoma cells by downregulating the expression
and activity of matrix metalloproteinase-9. Biochem Cell Biol.
93:16–27. 2015. View Article : Google Scholar
|
|
20
|
Zhou R, Xu L, Ye M, Liao M, Du H and Chen
H: Formononetin inhibits migration and invasion of MDA-MB-231 and
4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through
PI3K/AKT signaling pathways. Horm Metab Res. 46:753–760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hernández-Ledesma B, Hsieh CC and de Lumen
BO: Lunasin, a novel seed peptide for cancer prevention. Peptides.
30:426–430. 2009. View Article : Google Scholar
|
|
22
|
McCawley LJ and Matrisian LM: Matrix
metalloproteinases: multifunctional contributors to tumor
progression. Mol Med Today. 6:149–156. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hanemaaijer R, Verheijen JH, Maguire TM,
Visser H, Toet K, McDermott E, O'Higgins N and Duffy MJ: Increased
gelatinase-A and gelatinase-B activities in malignant vs. benign
breast tumors. Int J Cancer. 86:204–207. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zhang J and Hochwald SN: The role of FAK
in tumor metabolism and therapy. Pharmacol Ther. 142:154–163. 2014.
View Article : Google Scholar
|
|
25
|
Toutant M, Costa A, Studler JM, Kadaré G,
Carnaud M and Girault JA: Alternative splicing controls the
mechanisms of FAK autophosphorylation. Mol Cell Biol. 22:7731–7743.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Schlaepfer DD, Mitra SK and Ilic D:
Control of motile and invasive cell phenotypes by focal adhesion
kinase. Biochim Biophys Acta. 1692:77–102. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
van Nimwegen MJ and van de Water B: Focal
adhesion kinase: a potential target in cancer therapy. Biochem
Pharmacol. 73:597–609. 2007. View Article : Google Scholar
|
|
28
|
Wu JT and Kral JG: The NF-kappaB/IkappaB
signaling system: a molecular target in breast cancer therapy. J
Surg Res. 123:158–169. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hsieh CC, Hernández-Ledesma B and de Lumen
BO: Lunasin, a novel seed peptide, sensitizes human breast cancer
MDA-MB-231 cells to aspirin-arrested cell cycle and induced
apoptosis. Chem Biol Interact. 186:127–134. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Deryugina EI and Quigley JP: Matrix
metalloproteinases and tumor metastasis. Cancer Metastasis Rev.
25:9–34. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Pellikainen JM, Ropponen KM, Kataja VV,
Kellokoski JK, Eskelinen MJ and Kosma VM: Expression of matrix
metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special
reference to activator protein-2, HER2, and prognosis. Clin Cancer
Res. 10:7621–7628. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jezierska A and Motyl T: Matrix
metalloproteinase-2 involvement in breast cancer progression: a
mini-review. Med Sci Monit. 15:RA32–40. 2009.PubMed/NCBI
|
|
33
|
Takada Y, Ye X and Simon S: The integrins.
Genome Biol. 8:2152007. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Cabodi S, Di Stefano P, Leal MP,
Tinnirello A, Bisaro B, Morello V, Damiano L, Aramu S, Repetto D,
Tornillo G, et al: Integrins and signal transduction. Adv Exp Med
Biol. 674:43–54. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Meyer A, Auernheimer J, Modlinger A and
Kessler H: Targeting RGD recognizing integrins: drug development,
biomaterial research, tumor imaging and targeting. Curr Pharm Des.
12:2723–2747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dia VP and Gonzalez de Mejia E: Lunasin
induces apoptosis and modifies the expression of genes associated
with extracellular matrix and cell adhesion in human metastatic
colon cancer cells. Mol Nutr Food Res. 55:623–634. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
de Mejia EG, Wang W and Dia VP: Lunasin,
with an arginine-glycine-aspartic acid motif, causes apoptosis to
L1210 leukemia cells by activation of caspase-3. Mol Nutr Food Res.
54:406–414. 2010. View Article : Google Scholar
|
|
38
|
Inaba J, McConnell EJ and Davis KR:
Lunasin sensitivity in non-small cell lung cancer cells is linked
to suppression of integrin signaling and changes in histone
acetylation. Int J Mol Sci. 15:23705–23724. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Meyer T, Marshall JF and Hart IR:
Expression of alpha-V integrins and vitronectin receptor identity
in breast cancer cells. Br J Cancer. 77:530–536. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Rashidi LH, Homayoni H, Zou X, Liu L and
Chen W: Investigation of the strategies for targeting of the
afterglow nanoparticles to tumor cells. Photodiagnosis Photodyn
Ther. 13:244–254. 2016. View Article : Google Scholar
|
|
41
|
Shan D, Li J, Cai P, Prasad P, Liu F,
Rauth AM and Wu XY: RGD-conjugated solid lipid nanoparticles
inhibit adhesion and invasion of αVβ3
integrin-overexpressing breast cancer cells. Drug Deliv Transl Res.
5:15–26. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zeng F, Luo F, Lv S, Zhang H, Cao C, Chen
X, Wang S, Li Z, Wang X, Dou X, et al: A monoclonal antibody
targeting neuropilin-1 inhibits adhesion of MCF7 breast cancer
cells to fibronectin by suppressing the FAK/p130cas signaling
pathway. Anticancer Drugs. 25:663–672. 2014.PubMed/NCBI
|
|
43
|
Pal S, Moulik S, Dutta A and Chatterjee A:
Extracellular matrix protein laminin induces matrix
metalloproteinase-9 in human breast cancer cell line MCF-7. Cancer
Microenviron. 7:71–78. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Cao W, Zheng W and Chen T: Ruthenium
polypyridyl complex inhibits growth and metastasis of breast cancer
cells by suppressing FAK signaling with enhancement of
TRAIL-induced apoptosis. Sci Rep. 5:91572015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tian T, Nan KJ, Guo H, Wang WJ, Ruan ZP,
Wang SH, Liang X and Lu CX: PTEN inhibits the migration and
invasion of HepG2 cells by coordinately decreasing MMP expression
via the PI3K/Akt pathway. Oncol Rep. 23:1593–1600. 2010.PubMed/NCBI
|
|
46
|
Jung CH, Kim EM, Park JK, Hwang SG, Moon
SK, Kim WJ and Um HD: Bmal1 suppresses cancer cell invasion by
blocking the phosphoinositide 3-kinase-Akt-MMP-2 signaling pathway.
Oncol Rep. 9:2109–2113. 2013.
|
|
47
|
O-charoenrat P, Wongkajornsilp A,
Rhys-Evans PH and Eccles SA: Signaling pathways required for matrix
metalloproteinase-9 induction by betacellulin in head-and-neck
squamous carcinoma cells. Int J Cancer. 111:174–183. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Kane LP, Shapiro VS, Stokoe D and Weiss A:
Induction of NF-kappaB by the Akt/PKB kinase. Curr Biol. 9:601–604.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
de Mejia EG and Dia VP: Lunasin and
lunasin-like peptides inhibit inflammation through suppression of
NF-kappaB pathway in the macrophage. Peptides. 30:2388–2398. 2009.
View Article : Google Scholar : PubMed/NCBI
|
